United Therapeutics | UTHR - Loan Capital


United Therapeutics reported $100M in Loan Capital for its fiscal quarter ending in June of 2024.





Loan Capital Change Date
Ardelyx USD 203.52M 683K Mar/2026
Baxter International USD 8.62B 6M Jun/2026
Bayer EUR 30.68B 1.15B Mar/2026
BioCryst Pharmaceuticals USD 395.4M 203K Jun/2026
Biogen USD 7.29B 1B Jun/2026
BioMarin Pharmaceutical USD 3.53B 2.1B Jun/2026
Emergent BioSolutions USD 446.5M 1.7M Dec/2023
Gilead Sciences USD 20.86B 1.27B Mar/2026
GlaxoSmithKline GBP 13.95B 65M Jun/2026
Halozyme Therapeutics USD 1.94B 1.79M Jun/2026
Insmed USD 543.51M 1.3M Jun/2026
Ionis Pharmaceuticals USD 1.91B 6.62M Jun/2026
J&J USD 37.34B 183M Jun/2026
Lexicon Pharmaceuticals USD 49.68M 276K Mar/2026
Moderna USD 597M 6M Jun/2026
Omeros USD 403.72M 27.2M Jun/2024
Pfizer USD 60.5B 70M Jun/2026
PTC Therapeutics USD 535.52M 248.58M Jun/2026
Regeneron Pharmaceuticals USD 1.99B 400K Jun/2026
Sangamo BioSciences USD 0 0 Jun/2022
Sarepta Therapeutics USD 847.62M 9.46M Jun/2026
Teva Pharmaceutical Industries USD 12.09B 1.92B Jun/2026
United Therapeutics USD 100M 100M Jun/2024
Vertex Pharmaceuticals USD 106.7M 4.7M Dec/2025